tirzepatide programs Weight Loss Program for Patients Tirzepatide For Weight Loss |

Verified reviews

By comparison, in the SUSTAIN-7 trial, semaglutide 1 mg weekly (the highest approved dose) achieved approximately 17.5% weight loss

While semaglutide is generally safe and effective, being aware of potential side effects and safety concerns is crucial for patients

Sun Pharma, Dr Reddy's, Zydus plan early launch In December 2025, India's largest drug maker, Sun Pharmaceutical Industries, received Drug Controller General of India (DCGI) approval for manufacturing and marketing semaglutide injection for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise